menu
    • menu
    [{"orgOrder":0,"company":"Capital Medical University","sponsor":"CSPC-NBP Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CHINA","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Butylphthalide","moa":"Mitochondrial dysfunction","graph1":"Neurology","graph2":"Phase III","graph3":"Capital Medical University","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Capital Medical University \/ CSPC-NBP Pharmaceutical","highestDevelopmentStatusID":"10","companyTruncated":"Capital Medical University \/ CSPC-NBP Pharmaceutical"},{"orgOrder":0,"company":"Jinling Hospital, China","sponsor":"CSPC-NBP Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"CHINA","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Butylphthalide","moa":"Mitochondrial dysfunction","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"Jinling Hospital, China","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Jinling Hospital, China \/ CSPC-NBP Pharmaceutical","highestDevelopmentStatusID":"10","companyTruncated":"Jinling Hospital, China \/ CSPC-NBP Pharmaceutical"},{"orgOrder":0,"company":"Xiangya Hospital, Central South University","sponsor":"CSPC Pharmaceutical Group","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"CHINA","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Butylphthalide","moa":"Mitochondrial dysfunction","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"Xiangya Hospital, Central South University","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Xiangya Hospital, Central South University \/ CSPC Pharmaceutical Group","highestDevelopmentStatusID":"10","companyTruncated":"Xiangya Hospital, Central South University \/ CSPC Pharmaceutical Group"},{"orgOrder":0,"company":"CSPC-NBP Pharmaceutical","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CHINA","productType":"Miscellaneous","year":"2016","type":"Inapplicable","leadProduct":"n-Butylphthalide","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase II","graph3":"CSPC-NBP Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Softgel Capsule","sponsorNew":"CSPC-NBP Pharmaceutical \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"CSPC-NBP Pharmaceutical \/ Undisclosed"},{"orgOrder":0,"company":"Conjupro Biotherapeutics","sponsor":"CSPC-NBP Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"n-Butylphthalide","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase II","graph3":"Conjupro Biotherapeutics","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Softgel Capsule","sponsorNew":"Conjupro Biotherapeutics \/ CSPC-NBP Pharmaceutical","highestDevelopmentStatusID":"8","companyTruncated":"Conjupro Biotherapeutics \/ CSPC-NBP Pharmaceutical"}]

    Find Clinical Drug Pipeline Developments & Deals for Butylphthalide

    Menu

    Butylphthalide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Xiangya Hospital, Central South University

                            Country arrow
                            Global ChemShow
                            Not Confirmed

                            Xiangya Hospital, Central South University

                            Country arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Phase III

                            Sponsor : CSPC Pharmaceutical Group

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction S...

                            Details : Butylphthalide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of ST Elevation Myocardial Infarction.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            November 26, 2024

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Phase III

                            Sponsor : CSPC Pharmaceutical Group

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Conjupro Biotherapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed

                            Conjupro Biotherapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Oncology

                            Study Phase : Phase II

                            Sponsor : CSPC-NBP Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

                            Details : N-Butylphthalide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Breast Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            December 19, 2020

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase II

                            Sponsor : CSPC-NBP Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Capital Medical University

                            Country arrow
                            Global ChemShow
                            Not Confirmed

                            Capital Medical University

                            Country arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Neurology

                            Study Phase : Phase III

                            Sponsor : CSPC-NBP Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia

                            Details : Butylphthalide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Dementia, Vascular.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            January 15, 2019

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase III

                            Sponsor : CSPC-NBP Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            CSPC-NBP Pharmaceutical

                            China arrow
                            Global ChemShow
                            Not Confirmed

                            CSPC-NBP Pharmaceutical

                            China arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Endocrinology

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            NBP in Adult Patients With Acute Ischemic Stroke (AIS)

                            Details : N-Butylphthalide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Androgen-Insensitivity Syndrome.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            September 19, 2016

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Jinling Hospital, China

                            Country arrow
                            Global ChemShow
                            Not Confirmed

                            Jinling Hospital, China

                            Country arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Phase III

                            Sponsor : CSPC-NBP Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting

                            Details : Butylphthalide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Restenosis.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            July 29, 2011

                            Lead Product(s) : Butylphthalide

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Phase III

                            Sponsor : CSPC-NBP Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth